حدد سهمًا أو عملة مشفرة في شريط البحث للحصول على ملخص
Drägerwerk AG & Co. KGaA (pref)
DRW3Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. Its products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, hospitable consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services. The company's product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices. In addition, it offers various training and services, as well as fire training facilities for firefighters. The company was founded in 1889 and is headquartered in Lübeck, Germany. Drägerwerk AG & Co. KGaA operates as a subsidiary of Stefan DrÄGer Gmbh. Address: Moislinger Allee 53-55, Lübeck, Germany, 23558
Analytics
سعر الهدف في وول ستريت
54.81 EURنسبة السعر إلى الأرباح
7.4419العائد الربحي
4.25 %السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
الشخصيات الرئيسية DRW3
تحليلات الأرباح DRW3
نمو الأرباح على مدى 5 سنوات
-59 %النمو المستمر
1 سنةمعدل الدفع 5 سنوات في المتوسط
3 %تاريخ الأرباح DRW3
تقييم الأسهم DRW3
المالية DRW3
نتائج | 2019 | ديناميات |